Extranodal natural killer/t-cell lymphoma, nasal type, in a patient with a constitutional 11q terminal deletion disorder

Acta Haematol. 2007;118(1):42-6. doi: 10.1159/000101998. Epub 2007 Apr 27.

Abstract

Background: Most cases of constitutional 11q terminal deletion disorder are children. Malignancy is a potential concern, as these children reach adulthood. However, since the majority of patients are young, their risk of developing malignancy in adulthood is essentially unknown.

Aim: To report the first hematologic malignancy [extranodal natural killer (NK)/T-cell lymphoma, nasal type] arising in the trachea of a patient with constitutional 11q terminal deletion disorder. Our patient is the oldest patient reported in the literature. It is of note that this cytogenetic abnormality has not been described as a recurring abnormality in extranodal NK/T-cell lymphoma.

Case report: A 36-year-old male with congenital psychomotor retardation was transferred to our hospital. Pathologic evaluation was diagnostic of extranodal NK/T-cell lymphoma, nasal type. Staging marrow was negative for lymphoma, but cytogenetic analysis revealed a constitutional deletion of chromosome 11 at band q23 [46,XY,del(11)(q23)(c)]. This abnormality was present in a subsequent bone marrow specimen, along with an acquired abnormality, namely an extra copy of part of the long arm of chromosome 1 translocated to the short arm of chromosome 14.

Conclusion: Patients with 11q terminal deletion disorder who reach adulthood may be predisposed to develop neoplasias by virtue of the constitutional deletion.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Biopsy, Needle
  • Chromosome Aberrations
  • Chromosome Deletion*
  • Chromosomes, Human, Pair 11*
  • Cytogenetic Analysis
  • Disease Progression
  • Fatal Outcome
  • Humans
  • Immunohistochemistry
  • Killer Cells, Natural / pathology
  • Lymphoma, T-Cell, Peripheral / genetics*
  • Lymphoma, T-Cell, Peripheral / pathology*
  • Male
  • Nasal Mucosa / pathology
  • Nose Neoplasms / genetics*
  • Nose Neoplasms / pathology*
  • Severity of Illness Index